CBAY - CymaBay Therapeutics Inc. (CBAY) CEO Sujal Shah on Q4 2021 Results - Earnings Call Transcript
CymaBay Therapeutics, Inc. (CBAY) Q4 2021 Earnings Conference Call March 17, 2022 16:30 ET CompanyParticipants Paul Quinlan - General Counsel Sujal Shah - President & Chief Executive Officer Daniel Menold - Vice President of Finance Charles McWherter - Chief Scientific Officer Dennis Kim - Chief Medical Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler & Co. Steven Seedhouse - Raymond James Thomas Yip - H.C. Wainwright & Co. Jay Olson - Oppenheimer Alethia Young - Cantor Fitzgerald & Co. Sahil Kazmi - B. Riley Securities Michael Kratky - SVB Leerink Presentation Operator Good day ladies and gentlemen and welcome to CymaBay's Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the company’s request.
For further details see:
CymaBay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q4 2021 Results - Earnings Call Transcript